Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

10rx vs Rixa Health

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
10rx logo

10rx

8.1
★★★★4.1/5

Best for: semaglutide at $99.67/month, 47% under the register median

Visit 10rx
VS
Rixa Health logo

Rixa Health

4.6
★★☆☆☆2.3/5

Best for: coverage in all 50 states, which most of the register will not confirm

Visit Rixa Health

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, 10rx starts at $99.67/mo, and 10rx finishes ahead, 8.1 to 4.6. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

10rx

Injectablecompounded injection
$99.67/mo
semaglutide

Compounded; GLP-1 options as low as under $100/mo

Injectablecompounded injection
$149.67/mo
tirzepatide

Compounded GLP-1 + GIP

Rixa Health

Pricing not publicly listed.

What’s included

10rx

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Rixa Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

10rx

8.1/10

Overall

Rixa Health

4.6/10

Value25%

9.6A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
5.0

User Experience15%

8.0A
vs
B
2.5

Trust & Safety15%

5.5A
vs
B
5.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
5.0

Features & Coverage

Feature10rxRixa Health
Starting Price$99.67/mo
Features8 features8 features
States AvailableNot disclosed50
Compounded
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

About 10rx

10rx sets flat monthly rates on compounded GLP-1: semaglutide at $99.67, tirzepatide at $149.67, with NAD+ and sermorelin sold separately for energy and recovery. A free health quiz online reaches a board-certified telehealth doctor, who reads your history before writing anything, and licensed pharmacy partners handle discreet delivery. The company states it reaches every one of the 50 states. What it does not state is its operating company, its pharmacies, or any terms page.

Read our full 10rx review →

About Rixa Health

Rixa Health bundles weight-loss medication and visits into one price and does not charge until after approval. The direct-to-consumer functional-medicine practice prescribes compounded and oral semaglutide and tirzepatide, plus other peptides, through partner US pharmacies. Board-certified DO and FNP providers take a root-cause approach and require monthly follow-ups for the first six months. It is cash-pay only and available in nearly all states, with a few listed as coming soon. Compounded, not branded, GLP-1 is the focus.

Read our full Rixa Health review →

Pros & Cons

10rx

What we like

  • Semaglutide at $99.67 a month, 47% below the $189 median for the same drug and form across this register
  • Tirzepatide at $149.67 a month, 44% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly figure covers medication, consult, shipping
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Rixa Health

What we like

  • The monthly figure covers medication and consult
  • Coverage is published for all 50 states
  • No FDA warning letter matched this operator when we searched our enforcement register
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake

Watch-outs

  • No price appears until the medical intake is complete, so the cost cannot be compared before health information is submitted
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here

Our Verdict

Winner: 10rx

10rx takes it, 8.1 against 4.6, and it is especially strong on semaglutide at $99.67/month, 47% under the register median. Rixa Health is no weak second and may fit you better on coverage in all 50 states, which most of the register will not confirm.

Choose 10rx if…

You want semaglutide at $99.67/month, 47% under the register median and an opening price near $99.67 a month.

Choose Rixa Health if…

You want coverage in all 50 states, which most of the register will not confirm.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.4

Trimi Health

Knowing which pharmacy fills the vial — it names VialsRx

8.5

Strut Health

Semaglutide at $99/month, 48% under the register median

7.9

Oak

Semaglutide at $119/month, 37% under the register median

10rx vs Rixa Health: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring 10rx and Rixa Health head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.